The short version
Anthropic has not listed yet, so you cannot buy ANT shares today. Reporting points to first trading on 19 November.
What is confirmed: Anthropic filed its public Form S-1 with the SEC on 26 October 2026, and has applied to list Class A common stock on the Nasdaq Global Select Market under the ticker ANT. Goldman Sachs and Morgan Stanley are leading the offering.
UPDATED 10 NOVEMBER: the roadshow has launched and the terms are now set in preliminary form. Anthropic filed an amended S-1 proposing a price range of $70 to $78 per share on 825 million shares, raising up to about $64.4 billion and valuing the company at up to roughly $1.4 trillion fully diluted.
What is still not fixed: the final price, which is set at pricing and can land inside, above or below the range, and the dates, which Anthropic has not announced.
What is reported: pricing on 18 November and first trading on 19 November, with around 20% of the offering targeted at retail investors, far above the norm. All from CNBC citing people familiar with the plans. Anthropic has not confirmed any of it.
The most useful thing to understand before then: most individual investors do not buy at the IPO price. Allocations go largely to institutions. Individuals generally buy on the open market after trading begins, at whatever price the market sets, which is often well above the offer price.
And one figure from the filing that belongs in any discussion of this company: Anthropic reported a net loss of $80.7 billion in the first half of 2026, dominated by financing-related accounting charges, alongside revenue of $16.29 billion.
People are searching:
- “Anthropic IPO”
- “Anthropic IPO date”
- “ANT stock”
- “ANT ticker”
- “Anthropic stock price”
- “how to buy Anthropic shares”
- “can I buy Anthropic stock”
- “Claude company stock”
- “Claude AI stock”
- “who owns Claude”
- “Anthropic valuation”
- “Anthropic S-1”
- “Anthropic IPO price”
- “Anthropic Nasdaq listing”
- “buy IPO shares UAE”
- “how to invest in IPOs from Dubai”
- “AI stocks UAE”
Explore global stocks and ETFs from $1 on Nemo.money, with zero commission, and uninvested cash earns 6% AER interest, paid daily in USD.
What Is Anthropic, and What Does It Have to Do With Claude?
Anthropic is the company that makes Claude, the AI assistant. If you have used Claude, you have used Anthropic’s product.
- 🏢 Founded in 2021, headquartered in San Francisco, with around 5,300 employees as of September 2026.
- 🤖 Its main product is Claude, sold to consumers, businesses and developers, alongside Claude Code for software development.
- 🏛️ It is a public benefit corporation, which is a US company structure that commits a business to a stated public purpose alongside profit.
- 💰 Last valued privately at $965 billion, in a Series H round in May 2026.
It is one of two companies usually named as leaders in frontier AI, the other being OpenAI, which has said it will not list in 2026.
Anthropic IPO Date: What Do We Actually Know?
The timetable is now reported rather than hypothetical.
- 📄 26 October 2026: public Form S-1 filed with the SEC, following a confidential draft on 1 June 2026.
- 🎤 10 November 2026: roadshow launched with an amended S-1 setting the price range and share count.
- 📅 18 and 19 November 2026: reported pricing and first trading dates, not announced by Anthropic.
The earlier floor has been overtaken by events, but the reasoning is worth keeping. SEC rules require a minimum period between a public filing and pricing. The earliest a roadshow could begin was 10 November, the earliest pricing 13 November because the SEC is closed on 11 November, which made 16 November the first possible trade.
None of that is a commitment. Offerings get delayed, repriced or withdrawn, and Anthropic has announced nothing.
The SpaceX precedent turned out to be close. SpaceX filed publicly on 20 May and first traded on 12 June, a gap of 23 days. On that pace Anthropic would have debuted on 18 November. Reporting now points to pricing on the 18th and trading on the 19th, one day later than the comparison implied.
And two practical constraints narrowed the window:
- 📆 Friday 13 November was technically possible but unlikely. Bankers rarely price on a Friday, because the stock would not trade until Monday and buyers would sit on the position over a weekend.
- 🦃 Thanksgiving falls on 26 November. Between that and the US midterm elections on 3 November, Anthropic and its banks have a narrow run.
What Does the Filing Show?
The growth is extraordinary and so are the losses. Both are in the same document.
- 📈 First-half 2026 revenue: $16.29 billion, against $1.16 billion in the first half of 2025.
- 📊 Second-quarter revenue: $11.56 billion, with operating income of $974 million.
- 🚀 Third-quarter revenue: $16.95 billion, up about 1,127% year on year and 46% on the previous quarter.
- 💸 First-half net loss: $80.7 billion, dominated by financing-related accounting charges rather than operating costs.
- 📉 Third-quarter net loss: $23.29 billion, with adjusted operating income of $2.5 billion.
- 🏷️ Last private valuation: $965 billion, set in a Series H round in May 2026.
The gap between those numbers needs explaining. A loss of that size is not the cost of running the business. It largely reflects accounting charges connected to how the company has been financed, which is common at companies that have raised enormous sums privately before listing.
Which is why operating income and net loss point in opposite directions, and why anyone reading this filing needs to look at both. It is the same discipline we have applied all month, at Alphabet, Amazon and Xerox: find out what sits between the operating line and the bottom line.
We covered the filing in detail when it landed, including what the prospectus says about risk and founder control.
One more number for context. The last private valuation was $965 billion. The proposed range values the company well above that, and there is no guarantee the final price lands where the range suggests.
Can I Buy Anthropic Stock?
This is the part most coverage skips, and it is the part that decides what you can realistically do.
First, what most people mean by “buying an IPO” usually does not apply to most people. Before a company lists, the banks running the deal distribute shares at an agreed price, and those allocations go overwhelmingly to institutional investors: funds, pensions, large clients.
This offering may be a partial exception. Reporting suggests around 20% is targeted at retail investors, well above the norm for a deal of this size. That is reported rather than confirmed by Anthropic, access would depend on your broker, and reserved is not the same as received.
For most individual investors, the realistic route is to wait for the listing and buy the share on the open market.
Once trading begins, anyone whose broker offers the stock can buy it like any other share, at whatever price the market is quoting.
- ✅ You own the underlying asset, with no borrowing involved.
- 💵 Your maximum loss is what you put in.
- 📊 There is a discovered price, set by the market rather than estimated.
- ⏳ You have to wait, and the opening price may be well above the offer price.
Two questions worth answering before you do:
- ⏳ Is day one the right day? It is the most volatile and least informed day in a stock’s life, and nothing requires you to participate in it.
- 🔍 What does your provider actually offer, and on what terms?
You will be able to invest in ANT as a listed share with Nemo.money once the IPO completes and trading begins, from $1 with zero commission. As with any offering, the listing itself is subject to Anthropic completing it.
If you want the mechanics in general, our guide to buying US shares from the UAE covers account opening, funding in dollars, market hours and fractional investing. Those steps are the same whichever stock you are researching.
Are IPOs a Good Investment? What the Research Says
This is not about Anthropic specifically. It is about the category.
As we set out in our IPO explainer, the long-run evidence on newly listed companies is sobering: IPOs have tended to underperform comparable established companies over the following three to five years, and more than half of individual IPOs lose money over that period.
The larger study is more sobering still. Research by Professor Jay Ritter of the University of Florida, covering more than 9,000 IPOs between 1975 and 2021, found that 60% were flat or lower three years after their first day’s closing price.
The listing everyone compares this one to is instructive in both directions. A newly listed company of this size typically gets an early boost from index funds obliged to buy it. SpaceX got exactly that, and still fell about 15% in its first week in the Nasdaq-100.
But the business has since delivered. SpaceX reported third-quarter revenue of $14.58 billion, up 161% year on year and well ahead of the roughly $12.7 billion expected, alongside its first quarterly profit as a public company at $4.40 billion, having lost $1.05 billion in the same quarter a year earlier.
Both things are true at once, and that is the point. A share price can fall while a company executes, because the price reflects what was already expected rather than what was delivered. It is the same lesson we found at Reddit, which grew revenue 53% and fell 25% in a day.
The takeaway is not that listings go badly. It is that early price moves and business performance are separate things, and the first tells you very little about the second.
That finding sits awkwardly beside the excitement around any particular listing, which is exactly why it is worth stating before one rather than after.
Two recent examples from our own coverage, pointing in different directions:
- 🚀 SpaceX listed in June at $135 a share, in a record listing.
- ⏸️ Oura pulled its listing despite demand reported at four times the offering, a reminder that a hot product and a completed IPO are different things.
What could go wrong
- 📅 The terms are preliminary, not final. A price range is not a price, and the dates are reported rather than announced. Offerings get repriced, delayed or withdrawn.
- 💸 The losses are enormous. An $80.7 billion half-year net loss is dominated by financing-related charges rather than operations, and it still needs understanding rather than dismissing.
- 🏷️ The valuation moved before the deal did. Expectations fell from around $2 trillion a few weeks ago toward the current range, following a sharp selloff in AI shares.
- 📊 Day one is the least informed day. There is no trading history, no public quarterly track record, and the most volatile pricing a stock will ever see.
- 🔒 Lock-up expiries come later. Early investors and employees are typically restricted from selling for a period after listing. When that ends, supply increases.
- 🤖 And the sector is being repriced. Large AI-exposed stocks lost significant value in October, which is the backdrop this listing arrives into.
ANT is not currently available to buy, and nothing here is a recommendation to buy it when it is.
What should investors take from this?
Separate the company from the share price, and the share price from the offer price.
Anthropic is a significant company with extraordinary revenue growth. That tells you very little about whether its shares will be well priced on day one, and still less about where they go afterwards.
Three habits:
- 📄 Read the filing, not the coverage. The S-1 is public and contains the company’s own statement of its risks.
- ⏳ Let a listing establish a record. There is no obligation to participate on day one, and a few quarters of public reporting tells you more than any prospectus.
- 🧺 Remember the diversified route. If the interest is AI broadly rather than one company, funds spread exposure across many names, including most of the companies supplying this one.
Research US-listed stocks on Nemo.money
- From $1. Fractional investing, in research-sized amounts.
- Zero commission on US stocks and ETFs.
- Nemes: curated themed collections to start from.
- 6% AER interest on uninvested cash, paid daily in USD.
FAQs
When is the Anthropic IPO? Anthropic launched its roadshow on 10 November 2026. Reporting points to pricing on 18 November and first trading on 19 November under the ticker ANT, though Anthropic has not confirmed these dates.
What is the Anthropic ticker? The company has applied to list Class A common stock on the Nasdaq Global Select Market under the symbol ANT.
Can I buy Anthropic shares now? No. Anthropic remains a private company until the offering completes, so there is no stock to own. Reporting points to first trading on 19 November.
Will I be able to buy at the IPO price? Most individual investors do not get an allocation at the offer price, though reporting suggests around 20% of this offering is targeted at retail investors, which is well above the norm. Access would depend on your broker, and the allocation is decided at pricing.
How much is Anthropic worth? The amended filing proposes a price range of $70 to $78 per share, valuing the company at up to roughly $1.4 trillion fully diluted. Its last private valuation was $965 billion in May 2026. You will see $1.3 trillion and other figures elsewhere, because different counts include different share classes and instruments.
Can I invest in US-listed shares from the UAE? Yes. On Nemo.money you can research and invest in US-listed stocks and ETFs from $1 with zero commission, with uninvested cash earning 6% AER interest, paid daily in USD. Your capital is at risk.
Nemo = Never Miss Out.
Stay informed. Stay ahead.
#Anthropic #IPO #ANT #AI #Investing #NemoMoney
Terms and conditions apply. This is not investment advice. Past performance is not indicative of future results. Your capital is at risk. See website for Risk Disclosure. Exinity ME Ltd (https://nemo.money) is regulated by ADGM’s Financial Services Regulatory Authority.
